Podcasts about perioperative care

In this piece we discuss perioperative medicine with Ramani Moonesinghe, an anaesthetist and intensive care specialist from London, England, and Phuong Markman, an anaesthetist from Cairns, Australia. We explore access to and outcomes from surgery, particularly in relation to remoteness and socioeconomic deprivation. Then we talk about specific interventions to improve the patient experience, such as Sip til Send, and the challenges of implementing the program and demonstrating that it's safe with respect to aspiration. Finally we discuss whether AI and robotics can assist patients in the perioperative journey. Presented by Andy Cumpstey and Kate Leslie on location at the Annual Scientific Meeting of the Australian and New Zealand College of Anaesthetists and Faculty of Pain Medicine in Cairns, Australia, with their guests, Professor Ramani Moonesinghe, Professor of Perioperative Medicine, University College London, National Director of Patient Safety and National Clinical Director for Critical and Perioperative Care, NHS England, and Dr Phuong Markman, Consultant Anaesthetist, Cairns Hospital, Australia.

Drs. Vijaya Gottumukkala and Nicholas Perry discuss the article “Cancer Biology and the Perioperative Period: Opportunities for Disease Evolution and Challenges for Perioperative Care” published in the April 2025 issue of Anesthesia & Analgesia.

In this special episode of Value-Based Care Insights, host Daniel Marino brings you exclusive interviews recorded live at HIMSS25, where healthcare innovation took center stage. The first interview features Stephen Overman, CEO & Founder of Standpoint Solutions, who shares their groundbreaking technology aimed at improving communication within perioperative services. Next, Dr. Alan Young, Client Executive at Point B Solutions, dives into the transformative role of artificial intelligence in patient care. The future of AI-driven healthcare is explored, including the rise of intelligent agents and their potential to influence clinical decision-making. Tune in for an insightful discussion on the future of healthcare, technology, and how innovation is reshaping patient care.

In the second of a two-part podcast from the Centre for Perioperative Care and the Royal College of Anaesthetists former CPOC Fellow Dr Sam Moore and Dr Stuart Connal explore shared decision making - its definitions, usage, and many nuances in the interaction between clinicians and patients.  This podcast features guests Dr Sam Finnikin, Dr Gemma Hughes, and Leila Finikarides, and is split into two separate episodes. Sam, Gemma, and Leila share their personal and professional perspectives on shared decision-making - its importance in the patient-clinician relationship, language, and even when the idea of a shared decision may be counterproductive.  For ideas to benefit your own clinical practice, and for insights into the latest research and practices in this area, make sure you listen to both parts of this fascinating conversation. 

In this first of a two-part podcast from the Centre for Perioperative Care and the Royal College of Anaesthetists former CPOC Fellow Dr Sam Moore and Dr Stuart Connal explore shared decision making - its definitions, usage, and many nuances in the interaction between clinicians and patients.  This podcast features guests Dr Sam Finnikin, Dr Gemma Hughes, and Leila Finikarides, and is split into two separate episodes. Sam, Gemma, and Leila share their personal and professional perspectives on shared decision-making - its importance in the patient-clinician relationship, language, and even when the idea of a shared decision may be counterproductive.  For ideas to benefit your own clinical practice, and for insights into the latest research and practices in this area, make sure you listen to both parts of this fascinating conversation. Listen out for the second episode which will be released the following week. 

Following his presentation at our 2024 Winter Symposium, Professor Ketan Dhatariya discusses Obesity Metabolic Syndrome and diabetes in an engaging and wide-ranging conversation.  In this podcast Ketan reflects on the possible false economy of limiting access to GLP-1 agonists, the need for a non-judgmental view of patients presenting with obesity, how an evolutionary viewpoint can usefully inform modern medicine, and just how tasty the woolly mammoths of Red Lion Square were. Related information: Perioperative Care of People with Diabetes Undergoing Surgery (The Centre for Perioperative Care) Definition and diagnostic criteria of clinical obesity, The Lancet Anaesthesia for the obese patient, BJA Education For more on this topic, listen to Ketan's academic collaborator Kariem El-Boghdadly discussing GLP-1 agonists in our recent podcast interview with him.

Drs. Girish Joshi and Troy Wildes discuss the article “Perioperative Care of Patients Using Wearable Diabetes Devices” published in the January 2025 issue of Anesthesia & Analgesia.

In the final episode of Series 4, Dr Alice Tsai and Dr Monica Ortenzi speak to Dr Deborah Keller about a paper she co-authored on optimising perioperative care in older adults.Link to join SAGES as a Candidate Member: https://www.sages.org/membership/candidate/Reference:Keller DS, Curtis N, Burt HA, Ammirati CA, Collings AT, Polk HC Jr, Carrano FM, Antoniou SA, Hanna N, Piotet LM, Hill S, Cuijpers ACM, Tejedor P, Milone M, Andriopoulou E, Kontovounisios C, Leeds IL, Awad ZT, Barber MW, Al-Mansour M, Nassif G, West MA, Pryor AD, Carli F, Demartines N, Bouvy ND, Passera R, Arezzo A, Francis N. EAES/SAGES evidence-based recommendations and expert consensus on optimization of perioperative care in older adults. Surg Endosc. 2024 Aug;38(8):4104-4126. doi: 10.1007/s00464-024-10977-7. Epub 2024 Jun 28. PMID: 38942944; PMCID: PMC11289045. If you enjoy this episode, why not subscribe to Inside Surgery so you don't miss out on future episodes?Would you like to become a part of the EAES family? Become a member via https://eaes.eu/become-a-member

For certain diagnoses and patients who meet clinical criteria, neuromodulation can provide profound, long-lasting relief that significantly improves quality of life. In this episode, Aaron Berkowitz, MD, PhD, FAAN speaks with Prasad Shirvalkar, MD, PhD, author of the article “Neuromodulation for Neuropathic Pain Syndromes,” in the Continuum® October 2024 Pain Management in Neurology issue. Dr. Berkowitz is a Continuum® Audio interviewer and a professor of neurology at the University of California San Francisco in the Department of Neurology and a neurohospitalist, general neurologist, and clinician educator at the San Francisco VA Medical Center at the San Francisco General Hospital in San Francisco, California. Dr. Shirvalkar is an associate professor in the Departments of Anesthesia and Perioperative Care, Neurological Surgery, and Neurology at Weill Institute for Neurosciences at the University of California, San Francisco in San Francisco, California. Additional Resources Read the article: Neuromodulation for Neuropathic Pain Syndromes Subscribe to Continuum: shop.lww.com/Continuum Earn CME (available only to AAN members): continpub.com/AudioCME Continuum® Aloud (verbatim audio-book style recordings of articles available only to Continuum® subscribers): continpub.com/Aloud More about the American Academy of Neurology: aan.com Social Media facebook.com/continuumcme @ContinuumAAN Host: @AaronLBerkowitz Guest: @PrasadShirvalka Full episode transcript available here Dr Jones: This is Dr Lyell Jones, Editor in Chief of Continuum, the premier topic-based neurology clinical review and CME journal from the American Academy of Neurology. Thank you for joining us on Continuum Audio, which features conversations with Continuum's guest editors and authors, who are the leading experts in their fields. Subscribers to the Continuum Journal can read the full article or listen to verbatim recordings of the article and have access to exclusive interviews not featured on the podcast. Please visit the link in the episode notes for more information on the article, subscribing to the journal, and how to get CME. Dr Berkowitz: This is Dr Aaron Berkowitz, and today I'm interviewing Dr Prasad Shirvalkar about his article on neuromodulation for painful neuropathic diseases, which appears in the October 2024 Continuum issue on pain management in neurology. Welcome to the podcast, and if you wouldn't mind, please introducing yourself to our listeners.  Dr Shirvalkar: Thanks, Aaron. Yes, of course. So, my name is Prasad Shirvalkar. I'm an associate professor in anesthesiology, neurology and neurological surgery at UCSF. I am one of those rare neurologists that's actually a pain physician.  Dr Berkowitz: Fantastic. And we're excited to have you here and talk to you more about being a neurologist in in the field of pain. So, you wrote a fascinating article here about current and emerging neuromodulation devices and techniques being used to treat chronic pain. And in our interview today, I'm hoping to learn and for our listeners to learn about these devices and techniques and how to determine which patients may benefit from them. But before we get into some of the clinical aspects here, can you first just give our listeners an overview of the basic principles of how neuromodulation of various regions of the nervous system is thought to reduce pain? Dr Shirvalkar: Yeah, I would love to try. But I will promise you that I will not succeed because I think to a large extent, we don't understand how neuromodulation works to treat pain, to describe or to define neuromodulation. Neuromodulation is often described as using electrical stimuli or a chemical stimuli to alter nervous system activity to really influence local activity, but also kind of distant network activity that might be producing pain. On one level, we don't fully understand how pain arises, specifically how chronic pain arises in the nervous system. It's a huge focus of study from the NIH Heal Initiative and many labs around the world. But acute pain, which is kind of when you stub your toe or you burn your finger, is thought to be quite different from the changes over time and the kind of plasticity that produces emotional, cognitive and sensory dimensions. Really what I think is its own disease, chronic pain, of which there are multiple syndromes when we use neuromodulation, either peripheral nerve stimulation or electrical spinal cord stimulation. One common or predominant theory actually comes from a paper in science from 1967 and people still use it, foundational theory and it's called the gate control theory. Two authors, Melzack and Wall, postulated that at the spinal level, there are, there's a local inhibitory circuit or, you know, there's a local circuit where if you provide input to either peripheral nerves or either spinal cord ascending fibers that to kind of summarize it, there's only so much bandwidth, you know, that nerves can carry. And so that if you literally pass through artificial signals electrically, that you will help gate out or block natural pathological but natural pain signals that might be arising from the periphery or spinal cord. So, you know, one idea is that you are kind of interfering with activity that's arising for chemical neuromodulation. The most common is something known as intrathecal drug infusion drug delivery ITTD for that we quite literally put a catheter in the spinal fluid, you know, at the level of the dorsal horn neurons that we think are responsible for perpetuating or creating the pain. Where's the pain generator? And you really, you can infuse local anesthetic, you can infuse opioids. And what's nice is you avoid a lot of systemic side effects and toxicity because it goes right to the spinal cord, you know, by infusing in the fluid. So there's a couple of modalities, but I will say just, like maybe all of our living experience, pain is in the brain. And so, we don't really understand, I would say, what neuromodulation is doing to the higher spinal or brain levels. Dr Berkowitz: Fascinating topic. And yeah, very interesting to hear both what our current understanding is that some of our current understanding is based on data that's 60 years old and that we're actually probably learning about pain by using these modulation techniques, even though we don't really understand how they might be working. So interesting feedback loop there as well as in as in the as in this land. So, your article very nicely organizes the neuromodulation techniques from peripheral to central. So, encourage our listeners to check out your article. And first before we get into some of the clinical applications, just to give the listeners the lay of the land, can you sort of lay out the devices and techniques available for treating pain at each level of the neuroaxis? We'll get into some of the indications in patient selection in a moment, but just sort of to lay out the landscape. What's available that you and your colleagues can use or implant at different levels when we're thinking of referring patients too? Dr Shirvalkar: Absolutely. So, starting from the least invasive or you know, over the counter patients can purchase themselves a TENS machine. Many folks listening to this have probably tried a TENS machine in the past. And the idea is that you put a couple of pads, at least two. So you have like a dipole or you have a positive and a negative lead and you basically inject some current. So, the pads are attached to a battery and you can put these pads over muscle. If you have areas where myofascial pain or sore muscles, you can put them, frankly, over nerves as well and stimulate nerves that are deeper. Most TENS machines kind of use electrical pulses that occur at different rates. You change the rates, you can change the amplitude and patient can kind of have control for what works best. Then getting slightly more invasive, we can often stimulate electrically peripheral nerves. To do this we implant through a needle, a small wire that consists of anywhere from one electrical contact to four or even eight electrical contact. What I think is particularly cool, like TENS, which is transcutaneous electrical nerve stimulation that goes through the skin. Peripheral nerve stimulation aims to stimulate nerves, but you don't have to be right up against the nerve. So, yeah. We typically do this under an ultrasound and you can visualize a nerve like the sciatic nerve, peroneal nerve, or you know, even if someone has an ulnar or a neuropathy, you know, that's the compression. There's a role obviously for surgery and release, but if they have predominantly pain, it's not related to a mechanical problem per se, you could prevent a wire from a peripheral nerve stimulator as far as one centimeter from a nerve and it'll actually stimulate that that modulated and then, you know, kind of progressing even more deeply. The spinal cord stimulation, SCS, it's probably the most ubiquitous or popular form of neuromodulation for pain. People use it for all kinds of diseases. But what it roughly involves is a trial period, which is a placement of either two cylindrical wires, not directly over the spinal cord, but actually in the epidural space, right? So, it's kind of like when you get an epidural injection or doing labor and delivery, when women get epidural catheters, placing spinal cord stimulator leads in that same potential space outside the dura, and you're stimulating through the dura to actually target the ascending dorsal column fibers. And so, you do a trial period or a test drive where the patients get these wires put in. They're coming out of the skin, they're connected to a battery, and they walk around at home for about a week, take careful notes, check in with them, and they keep a diary or a log about how much it helps. Separately. I will say it's hard to distinguish this, the placebo effect often, but you know, sometimes we want to use the placebo effect in clinical practice, but it is a concern, you know, with such invasive things. But you know, if the trial works well, right, you basically can either keep the leads where they are and place a battery internally. And it's for neurologists. You're familiar with deep brain stimulation. These devices are very similar to DVS devices, but they're specifically made for spinal cord stimulation. And there's now like seven companies that offer manufacturers that offer it, each with their own proprietary algorithm or workflow. But going yet more invasive, there is intrathecal drug delivery, which I mentioned, which involves placement of the spinal catheter and infusion of drug into spinal fluid. You could do a trial for that as well. Keep a patient in the hospital for a few days. You've all probably had experience with lumbar drains. It's something real similar. It just goes the other way. You know, you're infusing drugs, and it could also target peripheral nerves or nerve roots with catheters, and that's often done. And last but not least, there's brain stimulation. Right now, it's all experimental except for some forms of TMS or transcranial magnetic stimulation, which is FDA approved for migraine with aura. There are tens machine type devices, cutaneous like stimulators where you can wear on your head like a crown or with stickers for various sorts of migraines. I don't really talk about them too much in in the article, but if there's a fast field out there for adjunctive therapy as well,  Dr Berkowitz: Fantastic. That's a phenomenal overview. Just so we have the lay on the land of these devices. So, from peripheral essentially have peripheral nerve stimulators, spinal cord stimulators, intrathecal drug delivery devices and then techniques we use in other areas of neurology emerging for pain DBS deep brain stimulation and TMS transcranial magnetic stimulation. OK let's get into some clinical applications now. Let's start with spinal cord stimulators, which - correct me if I'm wrong - seem to be probably the most commonly seen in practice. Which patients can benefit from spinal cord stimulators? When should we think about referring a patient to you and your colleagues for consideration of implantation of one of these spinal cord stimulator devices?  Dr Shirvalkar: So, you know, it's a great question. I would say it's interesting how to define which patients or diagnosis might be appropriate. Technically, spinal cord stimulators are approved for the treatment of most recently diabetic peripheral neuropathy. And so, I think that's a really great category if you have patients who have been failed by more conservative treatments, physical therapy, etcetera, but more commonly even going back, neuropathic low back pain and neuropathic leg pain. And so, you think about it and it's like, how do you define neuropathic pain. Neuropathic pain is kind of broadly defined as any pain that's caused by injury or some kind of lesion in the somatosensory nervous system. We now broaden that to be more than just somatosensory nervous system, but still, what if you can't find a lesion, but the pain still feels or seems neuropathic. Clinically, if something is neuropathic, we often use certain qualitative descriptors to describe that type of pain burning, stabbing, electric light, shooting radiates. There's often hyperpathia, like it lingers and spreads in space and time as opposed to, you know, arthritis, throbbing dull pain or as opposed to muscle pain might be myofascial pain, but sometimes it's hard to tell. So, there aren't great decision tools, I would say to help decide. One of the most common syndromes that we use spinal cord stimulation for is what used to be called failed back surgery syndrome. We never like to, we now try to shy away from explicitly saying something is someone has failed in their clinical treatment. So, the euphemism is now, you know, post-laminectomy syndrome. But in any case, if someone has had back surgery and they still have a nervy or neuropathic type pain, either shooting down their legs and often there's no evidence on MRI or even EMG that that something is wrong, they might be a good candidate, especially if they're relying on long term medications that have side effects or things like full agonist opioids, you know that that might have side effects or contraindication. So, I would say one, it's not a first line treatment. It's usually after you've gone through physical therapy for sure. So, you've gone through tried some medications. Basically, if chronic pain is still impacting your life and your function in a meaningful way that's restricting the things you want to do, then it it's totally appropriate, I think, to think about spinal cord stimulation. And importantly, I will add a huge predictor of final court stimulation success is psychological composition, you know, making sure the person doesn't have any untreated psychological illness and, and actually making sure their expectations going in are realistic. You're not going to cure anyone's pain. You may and that's, you know, a win, but it's very unlikely. And so, give folks the expectation that we hope to reduce your pain by 50% or we want you to list personally, I like functional goals where you say what is your pain preventing you from doing? We want to see if you can do X,Y, and Z during the trial period. Pharmacostimulation right now. Yeah. Biggest indication low back leg pain, Diabetic peripheral neuropathy. There is also an indication for CRPS, complex regional pain syndrome, a lesser, I'd say less common but also very debilitating pain condition. For better or worse. Tertiary quaternary care centers. You often will see spinal cord stem used off label for neuropathic type pain syndromes that are not explicitly better. That may be for example, like a nerve injury that's peripheral, you know, it's not responding. A lot of this off label use is highly variable and, you know, on the whole at a population level not very successful. And so, I think there's been a lot of mixed evidence. So, it's something to be aware about.  Dr Berkowitz: That's a very helpful framework. So, thinking about referring patients to who have most commonly probably the patients with chronic low back pain have undergone surgery, have undergone physical therapy, are on medications, have undergone treatment for any potential psychological psychiatric comorbidities, and yet remain disabled by this pain and have a reasonable expectation and goals that you think would make them a good candidate for the procedure. Are those similar principles to peripheral nerve stimulation I wasn't familiar with that technique, I'm reading your article, so are the principles similar and if so, which particular conditions would potentially benefit from referral for a trial peripheral nerve stimulation as opposed to spinal cord stimulation?  Dr Shirvalkar: Yeah, the principles are similar overall. The peripheral nerve stimulation, you know, neuropathic pain with all the characteristics you listed. Interestingly enough, just like spinal cord stim, most insurances require a psychological evaluation for peripheral nerve stim as well. And we want to make sure again that their expectations are reside, they have good social support and they understand the kind of risks of an invasive device. But also, for peripheral nerve stem, specifically, if someone has a traumatic injury of an individual peripheral nerve, often we will consider it seeing kind of super scapular stimulation. Often with folks who've had shoulder injuries or even sciatic nerve stimulation. I have done a few peroneal nerve stimulations as well as occipital nerve stimulation from migraine, so oxygen nerve stimulation has been studied a lot. So, it's still somewhat controversial, but in the right patient it can actually be really helpful. Dr Berkowitz: Very helpful. So, these are patients who have neuropathic pain, but limited to one peripheral nerve distribution as opposed to the more widespread back associated pains, spine associated pains. Dr Shirvalkar: Yeah, Yeah, that's right. And maybe there's one exception actually to this, which is brachial plexopathy. So, you know, folks who've had something like a brachial plexus avulsion or some kind of traumatic injury to their plexus, there is I think good Class 2 evidence that peripheral nerve stem can work. It falls under the indication. No one is as far as to my knowledge, No one's done an explicit trial, you know PNS randomized controlled trial. Yeah, that's, you know, another area one area where PNS or peripheral nerve stems emerging is actually, believe it or not in myofascial low back pain to actually provide muscle stimulation. There are some, there's a company or two out there that seeks to alter the physiology of the multifidus muscle, one of your spinal stabilizer muscles to really see if that can help low back pain. And they've had some interesting results.  Dr Berkowitz: Very interesting. You mentioned TENS units earlier, transcutaneous electrical nerve stimulation as something a patient could get over the counter. When would you encourage a patient to try TENS and when would you consider TENS inadequate and really be thinking about a peripheral nerve stimulator?  Dr Shirvalkar: Yeah, you know TENS we think of as really appropriate for myofascial pain. Folks who have muscular pain, have clear trigger points or taught muscle bands can often get relief from TENS If you turn a TENS machine up too high, you'll actually see muscle infection. So, there's an optimal level where you actually can turn it up to induce, like, a gentle vibration. And so folks will feel paresthesia and vibrations, and that's kind of the sweet spot. However, I would say if folks have pain that's limited or temporary in time or after a particular activity, TENS can be really helpful. The unfortunate reality is TENS often has very time-limited benefits - just while you're wearing it, you know? So, it's often not enduring. And so that's one of the limitations. Dr Berkowitz: That's helpful to understand. We've talked about the present landscape in your article, also talk a little bit about the future and you alluded to this earlier. Tell us a little bit about some off label emerging techniques that we may see in future use. Who, which types of patients, which conditions might we be referring to you and your colleagues for deep brain stimulation or transcranial magnetic stimulation or motor cortex stimulation? What's coming down the pipeline here?  Dr Shirvalkar: That's a great question. You know, one of my favorite topics is deep brain stimulation. I run the laboratory that studies intracranial signals trying to understand how pain is processed in the brain. But, believe it or not, chronic pain is probably the oldest indication for which DBS has been studied. the first paper came out in 1960, I believe, in France. And you know, the, the original pivotal trials occurred even before the Parkinson's trial and so fell out of favor because in my opinion, I think it was just too hard or too difficult or a problem or too heterogeneous. You know, many things, but there are many central pain syndromes, you know, poststroke pains, there's often pains associated with Parkinson's disease, epilepsy, or other brain disorders for which we just don't have good circuit understanding or good targets. So, I think what's coming down the pipeline is a better personalized target identification, understanding where can we stimulate to actually alleviate pain. The other big trend I think in neuromodulation is using closed loop stimulation which means in contrast to traditional electrical stimulation which is on all the time, you know it's 24/7, set it and forget it. Actually, having stimulation respond or adapt to ongoing physiological signals. So that's something that we're seeing in spinal cord stem, but also trying to develop in deep brain stimulation and noninvasive stimulation. TMS is interestingly approved for neuropathic pain in Europe, but not approved by the FDA in the US. And so I think we may see that coming out of pipeline broader indication. And finally, MR guided focused ultrasound is, is a kind of a brand new technique now. You know, focused ultrasound lesions are being used for essential tremor without even making an incision in the skull or drilling in skull. But there are ways to modulate the brain without lesioning. And, you know, I think a lot of research will be emerging on that in the next five years for, for pain and many other neuronal disorders. Dr Berkowitz: That's fascinating. I didn't know that history that DBS was first studied for pain and now we think of it mostly for Parkinson's and other movement disorders. And now the cycle is coming back around to look at it for pain again. What are some of the targets that are being studied that are thought to have benefit or are being shown by your work and that of others to have benefit as far as DBS targets for, for chronic pain? Dr Shirvalkar: You know, that's a great question. And so, the hard part is finding one target that works for all patients. So, it may actually require personalization and actually understanding what brain circuit phenotypes do you have with regards to your chronic pain and then based on that, what target might we use? But I will say the older targets. Classical targets were periaqueductal gray, which is kind of the opioid center in your brain. You know, it's thought to just release large amounts of endogenous opioids when you stimulate there and then the ventral pusher thalamus, right. So, the sensory ascending system may be through gait control theory interferes with pain, but newer targets the answer singlet there's some interest in in stimulating there again, it doesn't work for everybody. We found some interesting findings with the medial thalamus as well as aspects of the caudate and other basal ganglion nuclei that we hopefully will be publishing soon in a data science paper.  Dr Berkowitz: Fantastic. That's exciting to hear and encourage all of our listeners to check out your article. That goes into a lot more depth than we had time to do in this short interview, both about the science and about the clinical indications, pros and cons, risks and benefits of some of these techniques. So again, today I've been interviewing Dr Prasad Shirvalkar, whose article on neuromodulation for painful neuropathic diseases appears in the most recent issue of Continuum on pain management in neurology. Be sure to check out Continuum Audio episodes from this and other issues. And thank you again to our listeners for joining today.  Dr Shirvalkar: Thank you for having me. It was an honor. Dr Monteith: This is Dr Teshamae Monteith, associate editor of Continuum Audio. If you've enjoyed this episode, you'll love the journal, which is full of in depth and clinically relevant information important for neurology practitioners. Use this link in the episode notes to learn more and subscribe. AAN members, you can get CME for listening to this interview by completing the evaluation at continpub.com/AudioCME. Thank you for listening to Continuum Audio.

Perioperative Care of the Transgender and Gender-Diverse by AORNJournal

In this episode, Dr. Mistry and Donna Lee are joined by another special guest this week, Dr. Buckley!  F. P. “Tripp” Buckley III, MD, is a board-certified surgeon and the Surgical Director of Digestive Health, a clinical partnership between Ascension Seton and UT Health Austin. He specializes in anti-reflux and esophageal surgery, assisting patients suffering from gastroesophageal reflux disease (GERD). Additionally, Dr. Buckley is an associate professor and serves as the Chief of the Division of Elective Surgery for the Dell Medical School Department of Surgery and Perioperative Care. Do you have the guts to learn about your gut?!? What stomach problems to you have? What does your pancreas do?  Do you need reflux surgery or just some Tums? Where exactly is your sphinter? Is a hiatal hernia too small or too large for surgery? How do you spell esophagus? Well, you must tune in to learn the answers to these thought-provoking questions.  To learn more about Dr. Buckley, visit https://uthealthaustin.org/directory/tripp-buckley and his number is (512 324-GERD, Clever!  Share this with your friends and follow us wherever you listen to podcasts! Voted top Men's Health Podcast, Sex Therapy Podcast, and Prostate Cancer Podcast by FeedSpot.Dr. Mistry is a board-certified urologist and has been treating patients in the Austin and Greater Williamson County area since he started his private practice in 2007.We enjoy hearing from you! Email us at armormenshealth@gmail.com and we'll answer your question in an upcoming episode.Phone: (512) 238-0762Email: armormenshealth@gmail.comWebsite: armormenshealth.comOur Locations:Round Rock Office970 Hester's Crossing RoadSuite 101Round Rock, TX 78681Lakeline Office12505 Hymeadow DriveSuite 2CAustin, TX 78750South Austin Office6501 South CongressSuite 1-103Austin, TX 78745Dripping Springs Office170 Benney LaneSuite 202Dripping Springs, TX 78620

In this 287th episode I welcome Drs. Kyle Sanchez and Dan Ellis to the show to discuss the perioperative care of transgender and gender-diverse Patients. We discuss terminology, different medications and surgeries that you may see, preop, intraop and postop considerations.Advertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy

Drs. Susan V. Bukata and Gina Woods discuss the perioperative care of patients with osteoporotic fractures and those with osteoporosis undergoing elective surgery.

Back to Basics 2.0: Perioperative Care of the Older Adult by AORNJournal

Travis Reece-Nguyen, MD, MPH, FAAP, and OpenAnesthesia Associate Editor Elisha Peterson, MD, MEd, FAAP, FASA, discuss perioperative care of transgender and gender diverse pediatric patients. Resources: OA Summary: Transgender and Gender-Diverse Patients: Anesthetic Considerations  van Rooyen, C., Aquino, N.J., Tollinche, L.E. et al. Perioperative Considerations for Gender-Affirming Surgery. Curr Anesthesiol Rep 13, 90–98 (2023). Link Sanchez K, Tollinche L, Reece-Nguyen T. Anesthesia for gender-affirming surgery: a practical review. Curr Opin Anaesthesiol. 2024;37(3):292-298. PubMed TRANSformed Anesthesia: Examining a Novel ERAS Pathway for Gender-Affirming Chest Reconstruction Surgery Link Sanchez KJ, Sanchez RA, Ben Khallouq B, Ellis DB. Perioperative Care of Transgender and Gender-Diverse Patients: A Biopsychosocial Approach. Anesth Analg. 2023;137(1):234-246. PubMed Reece-Nguyen T, Afonso AM, Vinson AE. Burnout, Mental Health, and Workplace Discrimination in Lesbian, Gay, Bisexual, Transgender, Queer/Questioning, Intersex, and Asexual Anesthesiologists. Anesthesiol Clin. 2022;40(2):245-255. Link

Perioperative Care of Neurodiverse Patients with Sean P. Antosh, MD, FAAP, introduced by OpenAnesthesia Associate Editor, Jamie Rubin, MD.

Our coverage of the Society for Obstetric Anesthesia and Perinatology (SOAP) brings a conversation about the importance of perioperative care to improve maternal outcomes. Key aspects include preoperative patient preparation, multimodal pain management, postoperative nausea and vomiting prevention, and early mobilization. Presented by Desiree Chappell, TopMedTalk co-editor in Chief and Monty Mythen, TopMedTalk's founder, with their guest with their guest Brendan Carvalho, Department of Anesthesiology, Perioperative and Pain Medicine Stanford University School of Medicine.

Integrative medicine can help enhance recovery and improve surgical outcomes. Karolyn talks with cardiac anesthesiologist and integrative medicine expert Rosanne Sheinberg, MD, about how integrative practitioners can help their patients create a more successful surgical experience and optimize recovery. About the Expert Rosanne Sheinberg, MD, is an associate professor of anesthesiology and pain medicine at the University of Washington, with expertise in anesthesiology, cardiac anesthesiology, and perioperative transesophageal echocardiography. Previously an assistant professor and the program director of the Adult Cardiothoracic Anesthesiology Fellowship Program at Johns Hopkins Hospital from 2011 to 2022, Sheinberg has a diverse background that includes performing as a ballet dancer and in musical theater before earning her MD from Johns Hopkins. She has completed multiple fellowships, including in Integrative Medicine at the University of Arizona under Dr. Andrew Weil and in medical acupuncture. Sheinberg has contributed significantly to the fields of integrative and pain medicine, holding several directorship and educational roles and authoring key modules on integrative medicine approaches to pain management and perioperative care.

Why is difficult to define relevant outcomes in Paediatric Anaesthesia research? Can adverse events be considered as relevant outcomes at all? In this episode, our host, Dr Nicola Groes Clausen, discusses with Prof. Laszlo Vutskits the relevant outcomes of Paediatric Anaesthesia and research. Join them in their enlightening discussion and get informed.Supported by ESPA

Welcome to the next installment of the Anesthesia Patient Safety podcast hosted by Alli Bechtel.  This podcast is an exciting journey towards improved anesthesia patient safety.Tune in today as we continue our coverage of the International Conference on Anesthesia Patient Safety 2024. We are discussing Anesthesia Professionals' Role in the Perioperative Care Environment with talks that focus on anesthesia patient safety in Japan and Korea, medication safety, and ideal perioperative management to optimize patients prior to surgery and anesthesia care.Additional sound effects from: Zapsplat.For show notes & transcript, visit our episode page at apsf.org: https://www.apsf.org/podcast/194-icaps-2024-recap-part-3-patient-safety-in-the-perioperative-care-environment/© 2024, The Anesthesia Patient Safety Foundation

This piece is a discussion which followed three presentations at the Evidence Based Perioperaive Medicine (EBPOM) World Congress in London on artificial intelligence in perioperative medicine. Although, for an informed listener, it will work as a standalone piece the presentations which it is in part a response to are here: Part one is here: https://topmedtalk.libsyn.com/ai-in-perioperative-care-part-1-ebpom-london-2023 Part two is here: https://topmedtalk.libsyn.com/artificial-intelligence-in-perioperative-care-part-2-ebpom-2023 Part three is here: https://topmedtalk.libsyn.com/ai-predictive-monitoring-to-prevent-hemodynamic-instability-and-deterioration-in-perioperative-and-acute-care-patients-ebpom-world-congress On the panel are; Feras Hatib, Vice President of the R&D Algorithms and Signal Processing organization for Critical Care and Vascular at Edwards Lifesciences in Irvine California, Adriane Chapman, Professor at University of Southampton, Head of Digital Health Research Group, Director for the Centre for Health Technologies and Sandy (Alexander) Jackson, specialty trainee in anaesthetics and intensive care medicine and a National Institute for Health and Care Research (NIHR) Doctoral Fellow at the University of Southampton. This piece is chaired by TopMedTalk's co-editor in Chief Mike Grocott, Professor of Anaesthesia and Critical Care Medicine at the University of Southampton.

“It's evolution, not revolution, we've got a long way to go. But I'm certainly really excited to be on this journey. And I hope some of you will want to come on that journey with us.” This piece looks at artificial intelligence (AI) in perioperative care. How and why can this new technology help? Presented by Sandy (Alexander) Jackson, specialty trainee in anaesthetics and intensive care medicine and an NIHR Doctoral Fellow at the University of Southampton.

“Every single one of you can and should go build an AI model. It's actually pretty simple these days. But then think about; what actually is the problem here? And where could the system go wrong?” This podcast opens up the first in a four part series here on TopMedTalk about a topic which has defined the last few years; what does the development of artificial intelligence (AI) systems mean for perioperative medicine, what will the benefits be and where do we already see potential challenges? This first part “An Introduction to AI” gets the conversation going. With a short introduction from Mike Grocott this piece is presented by Adriane Chapman, Professor at University of Southampton, Head of Digital Health Research Group, Director for the Centre for Health Technologies. This piece is taken from a four part presentation, three talks and a discussion, first given at Evidence Based Perioperative Medicine (EBPOM) 2023.

We are almost 4 years out from the ascent of the Cov*d crisis, but some voices still need to be heard. In this episode we interview ER doctor Alan Hopkins who shares his direct experience during the last few years. We discuss:His extensive medical training + backgroundThe lack of critical thinking early on in the crisisWhat/who threatened his medical licenseHow he protected his family from the chaosPolitics in medicine is a dangerous combinationWhat made him say NO to the jabbHis real thoughts on masks, Ivermectin, the VHow we can become an active participant in our health journeyGet discounted direct lab testing from Dr. Alan Hopkins HERE.Dr. Alan Hopkins is board-certified in Emergency Medicine and completed an A4M fellowship in Anti-Aging Medicine. He has extensive experience in endocrinology, disease prevention, and laboratory medicine. Dr. Hopkins is the current founder and CEO for YOURLABWORK.COM and is an affiliate physician with the Dell Medical School Department of Surgery and Perioperative Care. Dr. Hopkins has a tremendous interest in optimizing heath and promoting wellness initiatives. He believes strongly that when patients understand their medical care and can access it on their terms; they become a motivated participant in their health. Active patient participation drives better outcomes for providers, health systems, employers and most importantly...patients.WANNA HEAR YOUR VOICE ON OUR SHOW? Now you can send us voice memos on Speakpipe! Ask us a question or leave us a comment and we will play it in an upcoming show. Leave us a message here: https://www.speakpipe.com/TheMedicinPodcastOUR LINKS + DISCOUNTSMushyLove Latte (discount: MEDICIN)Immune Intel AHCCOur favorite Reishi KING CoffeeOrganifi (20% discount: MIMIFIT)See all our favorite products on The Medicin CabinetCONNECT WITH USOur websiteMimi's IG // Chase's IG // The Medicin IGSound from Zapsplat.com

Bedwetting is no joke when it impacts your child. In fact, my guest on this episode, considers it a “life spoiling issue.” It's not just your child wetting the bed, it's our reaction to it that is usually based in fear and leads us to shame or punish the child.Before you read any further, you must know that this is NOT.YOUR.CHILD'S.FAULT nor is it your fault! Let's end the shame and punishments around bedwetting here.My guest is Dr. Danielle Sweeney, of Austin, Texas who is a Pediatric Urologist and is a faculty member at Texas Children's Hospital. She wants every parent and caregiver to know that bed wetting isn't intentional, it doesn't mean there is anything wrong with the child and more children struggle with bedwetting than you know, even into the teen years.In this episode, Dr. Sweeney explains that bedwetting is tied to your child's development and how children develop at different speeds. She also discusses why it happens, what to do if your child starts wetting the bed, what issues might be going on and other medical issues that might get in the way. For Dr. Sweeney's handout, “Coping with Your Child's Bedwetting”, you can download it from the Parent Toolbox. www.parent-toolbox.comAbout Dr. Danielle Sweeney Dr. Danielle D. Sweeney is a is a board-certified Pediatric Urologist from Austin, Texas who is currently a member of the faculty of Texas Children's Hospital. She currently holds an adjunct faculty position with the University of Texas-Austin, Dell Medical School in the Department of Surgery and Perioperative Care. She did her undergraduate and medical school training at Tulane University in New Orleans, her Urologic Surgery Residency at the University of Pittsburgh, and her Pediatric Urology Fellowship at Children's Hospital of Pittsburgh. She also completed a Global Health Certificate Program at the Gillings School of Global Public Health at the University of North Carolina-Chapel Hill. Social Media:Web: www.vamiohealth.comFacebook: https://www.facebook.com/vamiohealthInstagram: https://www.instagram.com/vamiohealth/YouTube: https://www.youtube.com/@vamiohealthThanks for listening! For more on Robbin, her work and free resources, keep reading!FREE GUIDE FOR PARENTS OF STRONG-WILLED KIDS: “How to Turn a NO into Cooperation” go to www.strongwilledkids.comAbout RobbinRobbin's work focuses on building and strengthening the parent child relationship so that children grow up with resilience, confidence and strong emotional intelligence. She works with parents to help them understand their own emotions and frustrations in parenting, so they can help build their children's sense of self without losing themselves in the process! For more, go to www.parentingforconnection.com

Safety First Documenting Perioperative Care In The Electronic Health Record by AORNJournal

Safety First Documenting Perioperative Care In The Electronic Health Record by AORNJournal

In this month's podcast, Sam talks to Siri van der Meijden about the current uses of AI and machine learning in perioperative care. They discuss the challenges clinicians may face and ways to assess whether an AI model fits for different populations.

I made sure to end this season with a loud and shiny BANG! Diamonds...the most coveted gemstones in all of its beauty and radiance. Yet, their journey into brilliance is borne out of intense pressure and melting heat. This is true of our special guest today: primordial stories of pain and questions that have materialized with hard work and determination into a narrative of power and splendid success for the whole world to see.We are joined today by Dr. Tiffany Moon, board-certified anesthesiologist, associate medical professor, multi-business CEO, and TV personality. She received her BS from Cornell University in 2004, MD from the University of Texas Southwestern Medical School in 2008, and Anesthesiology residency at UC San Francisco in 2012. She has been an associate professor of Anesthesiology and Pain Management at UT Southwestern Medical Center for over ten years, where she received the Faculty of the Year Teaching Award in 2014. She is a fellow of the American Society of Anesthesiologists (FASA), a Board Director of the International Society for the Perioperative Care of the Obese Patient (ISPCOP), Oral Board Examiner of the American Board of Anesthesiology (ABA), and was inducted into the prestigious Association of University Anesthesiologists (AUA) in 2019. She has also published more than three dozen original manuscripts, reviews, and book chapters and speaks internationally on topics related to her research, which focuses on thoracic anesthesia, pain perception, difficult airways, and neuromuscular blockade and reversal.Outside of medicine, she stands as the Founder and CEO of Aromasthesia, a luxury candle company, and Three Moons Wine. On the spotlight and big screen, she appeared on The Real Housewives of Dallas (RHOD)'s fifth season, which aired in 2021.Livestream Air Date: November 10, 2022Tiffany Moon, MD, FASA, D.ABA: IG @tiffanymoonmd & TikTok @tiffanymoonmdFriends of Franz: IG @friendsoffranzpod & FB @friendsoffranzpodChristian Franz (Host): IG @chrsfranz & YT Christian FranzThankful to the season's brand partners: Clove, BETR Remedies, Eko, Lumify, RescueMD, Medical School for Kids, Your Skincare Expert, and Twrl Milk Tea.

Healthcare leaders from Blue Shield of California, CareSource, UT Health Austin and Vori Health discuss the importance of adopting a whole-person approach across the broader healthcare experience to maximize value, drive healthy behavior change and ensure more equitable care.    Learn how to develop an integrated whole-person solution framework and implement strategies to support members with chronic and high-risk conditions. Topics include: Adopting self-service digital tools and applications to engage members Providing access to resources, health coaches, medication, and mental/behavioral health support Leveraging medical and SDoH data to determine unique needs, tailor care, and sustain healthy behavior change   Panelists: Judith Davis, Vice President Clinical Operations, Ohio Market, CareSource, Angie Kalousek Ebrahimi, Senior Director, Lifestyle Medicine, Blue Shield of California, Karl Koenig, M.D., M.S., Executive Director, Musculoskeletal Institute; Division Chief of Orthopaedic Surgery, Associate Professor of Surgery and Perioperative Care, Dell Medical School, Ryan A. Grant, MD, MBA, FAANS, Founder and Chief Executive Officer, Vori Health Bios: https://www.brightspotsinhealthcare.com/events/reduce-total-cost-of-care-innovative-whole-person-models-for-high-cost-conditions/   Request discount code for our Payer & Provider Summit: https://www.brightspotsinhealthcare.com/summit-promo/ This episode is sponsored by Vori Health Vori Health is a specialty medical practice delivering a virtual-first musculoskeletal (MSK) solution to help members return to their lives faster. As the only nationwide MSK practice with doctor-led care teams, Vori Health is the most convenient way to access appropriate care for back, neck, and joint pain without bouncing around the healthcare system. Whether members need a diagnosis, non-opioid prescription, personalized physical therapy, or health coaching, they can turn to Vori Health for evidence-based care and effective end-to-end support. This holistic model reduces unnecessary surgeries, enables faster recoveries, and lowers MSK spending with up to a 4:1 ROI, for more information, visit www.vorihealth.com.

This piece is a conversation with two fascinating guests who are in attendance at the Australian and New Zealand College of Anaesthetists Annual Scientific Meeting (ANZCA). Desiree Chappell and Monty Mythen speak with Jill Van Acker, Specialist Anaesthetist, Canberra Hospitals, Chair Perioperative Medicine SIG, ACE, ANZCA, ASA, NZSA and Louise Speedy, Anesthetist and Intensive Care Specialist at Te Matau a Maui Hawkes Bay Hospital, New Zealand and Medical Officer for the New Zealand Army, Reserve Force Major with the Deployable Health Organisation. -- This year TopMedTalk is proud to be providing exclusive coverage of the annual Australian and New Zealand College of Anaesthetists (ANZCA) conference, the professional body responsible for the specialties of anaesthesia and pain medicine in Australia and New Zealand. For more on ANZCA go here: https://www.anzca.edu.au/ And join in the conversation by checking out their socials here: instagram.com/the_anzca/ https://facebook.com/ANZCA1992 https://youtube.com/AnzcaEduAu

Enjoy this sneak peak of Dr. Ralph Harvey's CE session from TVMA Annual Conference. Dr. Harvey currently works as a consultant in practice and industry promoting best medicine, including Fear Free practices, and new advances in patient care, with a focus on the management and relief of animal pain and suffering. Dr. Harvey formerly taught anesthesia and pain management in the Department of Small Animal Clinical Sciences at the University of Tennessee College of Veterinary Medicine in Knoxville, Tennessee. He has served as the section head for the Small Animal Surgical Services and as a member of the University Faculty Senate. His veterinary degree is from the UTCVM, and his post-graduate training included internship, residency and fellowship at Cornell's Veterinary and Medical Colleges. Dr. Harvey has worked in private small animal practice. He is certified as a specialist by the American College of Veterinary Anesthesia and Analgesia and has served as their executive secretary and as a member of the ACVAA Board of Directors. He currently is a member of the Fear-Free Executive Council. Support the show

This piece is a question and answer session, it's divided into two parts, this is part two. Following on from our previous podcasts, https://topmedtalk.libsyn.com/a-patients-perioperative-perspective-ebpom-world-congress / https://topmedtalk.libsyn.com/essential-update-the-center-for-perioperative-care-ebpom-world-congress / https://topmedtalk.libsyn.com/whats-new-in-education-and-training-in-perioperative-care-ebpom-world-congress this discussion is an invaluable and at points frank examination of perioperative care. What does it look like when ‘the rubber meets the road'? Hosted by Dave Selwyn, Deputy Medical Director at Nottingham University Hospitals NHS Trust and Director of The Centre for Perioperative Care (CPOC) and Mike Grocott, Professor of Anaesthesia and critical care at the University of Southampton. We join them as questions from the online audience are answered by the panel, which includes; Patient Advocate - Lawrence Mudford, enjoyed a 38-year healthcare career working as a dentist and dental educator within both primary and secondary care, Steven Evans, Center for Perioperative Care (CPOC) Fellow and anaesthetic trainee (ST7), Sophie Randall, Director of the Patient Information Forum and Scarlett McNally, Deputy Director for CPOC and honoree, Clinical Professor at Brighton and Sussex medical school and consultant orthopedic surgeon in East Sussex.

Following on from our previous podcasts, https://topmedtalk.libsyn.com/a-patients-perioperative-perspective-ebpom-world-congress / https://topmedtalk.libsyn.com/essential-update-the-center-for-perioperative-care-ebpom-world-congress / https://topmedtalk.libsyn.com/whats-new-in-education-and-training-in-perioperative-care-ebpom-world-congress this discussion is an invaluable and at points frank examination of perioperative care. What does it look like when ‘the rubber meets the road'? Hosted by Dave Selwyn, Deputy Medical Director at Nottingham University Hospitals NHS Trust and Director of The Centre for Perioperative Care (CPOC) and Mike Grocott, Professor of Anaesthesia and critical care at the University of Southampton. We join them as questions from the online audience are answered by the panel, which includes; Patient Advocate - Lawrence Mudford, enjoyed a 38-year healthcare career working as a dentist and dental educator within both primary and secondary care, Steven Evans, Center for Perioperative Care (CPOC) Fellow and anaesthetic trainee (ST7), Sophie Randall, Director of the Patient Information Forum and Scarlett McNally, Deputy Director for CPOC and honoree, Clinical Professor at Brighton and Sussex medical school and consultant orthopedic surgeon in East Sussex.

Cohosts Alexander Aleem, MD, FAOA, and Charles A. Goldfarb, MD, FAOA interview David Ring, MD, PhD, FAOA, about his role as Moderator for Symposium 5: Culture of Safety Across All Professional Endeavors, at the 2023 AOA Annual Meeting.Dr. Ring discusses his personal experience with culture of safety and how it has evolved in the fifteen years that he spent at Massachusetts General Hospital as the chair of orthopaedic and patient safety committee. He shared his perspective on the importance of patient safety and how doctors can help each other in order to create a safer hospital system. David Ring, MD, PhD, FAOA is a board-certified orthopedic surgeon and the Upper Extremity Clinical Director of UT Health Austin's Musculoskeletal Institute. He specializes in hand to shoulder surgery, of which common problems include pain, numbness, injury, infection, or a bump. Additionally, Dr. Ring is a professor in the Dell Medical School Department of Surgery and Perioperative Care and a courtesy professor in both the Dell Medical School Department of Health Social Work and the Dell Medical School Department of Psychiatry and Behavioral Sciences.

Welcome to the next installment of the Anesthesia Patient Safety podcast hosted by Alli Bechtel.  This podcast is an exciting journey towards improved anesthesia patient safety.Have you provided anesthesia care for a patient with an Mpox infection? Today we are going to review the current evidence and go through a framework for perioperative care for patients infected with Mpox. anesthesia professionals need to be prepared for infection prevention in the anesthesia work environment.Additional sound effects from: Zapsplat.© 2023, The Anesthesia Patient Safety FoundationFor show notes & transcript, visit our episode page at apsf.org: https://www.apsf.org/podcast/145-a-framework-for-perioperative-care-for-patients-infected-with-mpox/

Steven Evans, Center for Perioperative Care (CPOC) Fellow and anaesthetic trainee (ST7) provides a full update on what's new in education and training. Originally broadcast to the attendees (both online and in person) of the Evidence Based Perioperative Medicine (EBPOM) World Congress. What are the new innovations, attitudes and standards which are emerging as perioperative practice is pushed forward? If you enjoy this talk, please ensure you are subscribed to TopMedTalk; also ensure you are part of our EBPOM mailing list and go now to the www.ebpom.org site to check out incredible low prices for some of our forthcoming events and conferences.

“The Center for Perioperative Care (CPOC) was set up as a cross organisational collaboration with the patients at the heart of it; focusing on improving care ‘from the moment of contemplation of surgery, through the perioperative period, to recovery' and really hoping to change the emphasis from patients being ‘surgical patients' to patients 'being in the perioperative pathway'.” This piece was originally presented as a talk at the Evidence Based Perioperative Medicine (EBPOM) World Congress; “What work has The Center for Perioperative Care (CPOC) been doing?”. It is a full update, on behalf of CPOC, from Jugdeep Dhesi, Consultant Geriatrician, Guys and St Thomas' NHS Trust, Clinical Lead for "Proactive care for Older People undergoing Surgery" (POPS) and a Deputy Director of CPOC. For more on POPS go here: https://www.topmedtalk.com/sunday-special-the-pops-clinic-at-guys-st-thomass-2/ This exclusive update is provided to you for free by TopMedTalk, the broadcasting arm of EBPOM. If you would like to see or attend the EBPOM World Congress - go now to www.ebpom.org

Laurence Mudford (see full bio below) provides the patient perspective and here begins a discussion about perioperative care; what is it, what do people think it is, what should we make it? Taken from the Centre for Perioperative Care's (CPOC) outstanding contribution to the Evidence Based Perioperative Medicine's (EBPOM) World Congress; this piece is the first in a series which originally streamed on the EBPOM.org platform. Ensure you check out their site now as we offer incredible prices on this year's “World Congress”. See these podcasts live, before anyone else and interact with the panel via our easy to use interaction platforms and social media. The piece also features co-chairs Dave Selwyn, Deputy Medical Director at Nottingham University Hospitals NHS Trust and Director of The Centre for Perioperative Care (CPOC) and Mike Grocott, Professor of Anaesthesia and critical care at the University of Southampton. Lawrence Mudford has enjoyed a 38-year healthcare career working as a dentist and dental educator within both primary and secondary care. This has included serving on the Board of the Faculty of General Dental Practice (UK) and as a member of the General Dental Council. Following diagnosis and successful treatment for cancer in 2016, Lawrence has realigned his focus and combines his healthcare background with his passion to champion the “patient voice” In this capacity, he sits on the Board of the CPOC. More information about CPOC go here: https://cpoc.org.uk/

Cancer is a major global public health concern that affects all citizens and communities around the world. Globally, the incidence of cancer is predicted to increase by 50% by the year 2030; and during the same period, cancer-related mortality is projected to increase by 60% to 13.1 million deaths worldwide. This increasing trend in cancer-related mortality exists despite a slow but steady decline in cancer-related death rates since the early 1990s in the United States and the Western world.Citizens 65 years of age or older have a cancer incidence rate that is 10 times higher than among younger people, while the mortality rate among older cancer patients is 16 times greater than among younger patients. However, cancer is no longer considered a terminal disease. With the implementation of effective cancer prevention education programs, widely available screening programs leading to early diagnosis, and the advent of effective biologic and immunotherapeutic modalities, the profile of cancer is changing to a chronic medical condition.There are more than 20 million cancer survivors currently living in the United States alone. Of the nearly 20 million new cancer cases worldwide in 2021, more than 80% of cases will need surgery, some several times as curative resection is essential for global cancer control, particularly for patients with solid tumors. It is estimated that by 2030, over 45 million surgical procedures will be needed globally for cancer control. Furthermore, both patients with cancer and cancer survivors will continue to need the services of our specialty in the perioperative setting well beyond their primary cancer care.  As most of the diagnostic and interventional procedural care for patients with cancer is provided in the community setting around the world, this textbook, “Perioperative Care of the Cancer Patient,” will serve the educational needs of anesthesia providers in all settings globally. Each of the chapters is authored by international experts in the field and discusses the current understanding and practices, current controversies and unanswered questions, and the direction for future studies.  I believe this is an exciting time for anesthesiology and perioperative medicine as we continue to partner with oncology and other specialties to break down silos and work together to improve postoperative outcomes and increase disease-free survival.   

In 2022 we covered many live events and conferences both on the subject of anesthesia and perioperative medicine; we produced audio versions of some of the most interesting speakers in the field of perioperative medicine and provided you with exclusive interviews and behind the scenes access to some of the key opinion leaders and thinkers in medicine. That's not to mention occasional exclusive news releases, hard hitting debates and the friendly charm of your favorite presenters; Desiree, Monty, Sol, Mike and the rest of the team. Do ensure you've taken advantage of the current offers available now on the Evidence Based Perioperative Medicine (EBPOM) website: www.ebpom.org In this podcast: A preview of "The National Institute for Health and Care Research | EBPOM London" https://topmedtalk.libsyn.com/the-national-institute-for-health-and-care-research-ebpom-london - this link will be active upon release. We also look back at: "I know nothing..." Hugh Montgomery https://topmedtalk.libsyn.com/i-know-nothing-hugh-montgomery-ernest-henry-starling-plenary-lecture-ebpom-2022 The Great Fluid Debate | EBPOM 2022 https://topmedtalk.libsyn.com/the-great-fluid-debate-ebpom-2022 Novel Therapies for Perioperative Care. This from EBPOM Dingle 2022 https://www.topmedtalk.com/novel-therapies-for-perioperative-care-ebpom-dingle/ Efficient trial design, ‘evidence' in the era of ‘Big Data' | Dingle 2022 https://www.topmedtalk.com/efficient-trial-design-evidence-in-the-era-of-big-data-dingle-2022/ Enhanced Recovery After Cardiac Surgery (ERAS) - Is it really that different? | Dingle 2022 https://www.topmedtalk.com/enhanced-recovery-after-cardiac-surgery-eras-is-it-really-that-different-dingle-2022/ ASA Global Scholars - Part 1: https://www.topmedtalk.com/the-asa-global-scholars-program-part-1-anesthesiology-2022/ Part 2: https://www.topmedtalk.com/the-asa-global-scholars-program-part-2-anesthesiology-2022/

Hear the complete live session with questions from the online audience at one of the stand out presentations of Evidence Based Perioperative Medicine (EBPOM)'s Dingle Conference. Don't forget if you want full access to our video presentations on demand and are interested in attending the next EBPOM conference ensure you check out www.ebpom.org Here are the two articles referenced in this piece: Current status of perioperative hypnotics, role of benzodiazepines, and the case for remimazolam: a narrative review https://doi.org/10.1016/j.bja.2021.03.028 Intraoperative hypotension and the risk of postoperative adverse outcomes: a systematic review https://doi.org/10.1016/j.bja.2018.04.036 Presented by Desiree Chappell VP Clinical Quality for NorthStar Anesthesia and Vicki Morton, Director of Clinical and Quality Outcomes at Providence Anesthesiology Associates, P.A. with their guests; Rob Sneyd, Emeritus Professor, University of Plymouth, Jeff Gadsden, Associate Professor of Anesthesiology, Duke University, USA, Dru Riddle Associate Professor of Professional Practice and Director of Clinical Education, Fort Worth Texas.

00:57:49 The Ohio State University W

Perioperative care of the patient with alpha-gal syndrome by AORNJournal

Misinformation about COVID-19 (such as around vaccines, masks, and ineffective drugs) has circulated widely during the pandemic, and much of this misinformation is protected by the Free Speech Clause of the First Amendment. Professor of Surgery and Perioperative Care and Professor of Law William M. Sage, MD, JD, from the University of Texas at Austin, is interviewed in this JAMA podcast. Related Content: Reducing “COVID-19 Misinformation” While Preserving Free Speech

Misinformation about COVID-19 (such as around vaccines, masks, and ineffective drugs) has circulated widely during the pandemic, and much of this misinformation is protected by the Free Speech Clause of the First Amendment. Professor of Surgery and Perioperative Care and Professor of Law William M. Sage, MD, JD, from the University of Texas at Austin, is interviewed in this JAMA podcast. Related Content: Reducing “COVID-19 Misinformation” While Preserving Free Speech

Drs. Zeev Kain, Padma Gulur and Catriona Harrop discuss the article “Pro-Con Debate: Anesthesiologist versus Hospitalist Run Preoperative Clinics and Perioperative Care” published in the March 2022 issue of Anesthesia & Analgesia.

Perioperative care of the patient with alpha-gal syndrome by AORNJournal

Welcome back to Season 2, Episode 136 of the Asian Hustle Network Podcast! We are very excited to have Tiffany Moon on this week's show. We interview Asian entrepreneurs around the world to amplify their voices and empower Asians to pursue their dreams and goals. We believe that each person has a message and a unique story from their entrepreneurial journey that they can share with all of us. Check us out on Anchor, iTunes, Stitcher, Google Play Music, TuneIn, Spotify, and more. If you enjoyed this episode, please subscribe and leave us a positive 5-star review. This is our opportunity to use the voices of the Asian community and share these incredible stories with the world. We release a new episode every Wednesday and Saturday, so stay tuned! Award-winning anesthesiologist, frontline worker, supermom to 6-year-old twins, and philanthropist, Dr. Tiffany Moon, took over televisions this year as the first medical doctor and first-generation Chinese-American cast member in franchise history to be a part of “The Real Housewives of Dallas.” Now moving into the content-creating space, Dr. Moon has most recently launched her very own YouTube channel, “Paging Dr. Moon” with various lifestyle, medical, comedic, and other videos being released soon. With a love for all things pop culture, fashion, food, medical practice, and more, Dr. Tiffany Moon's new YouTube channel “Paging Dr. Moon” will offer fans and new viewers new content each week that will cover a wide variety of topics. Dr. Moon is passionate about medical student and resident education, and in 2014 she won the Dennis F. Landers, M.D., Ph.D. Faculty of the Year Teaching Award. She serves on multiple committees for the American Society of Anesthesiologists and is an Oral Board Examiner for the American Board of Anesthesiology. She also serves on the Board of Directors for the International Society for the Perioperative Care of the Obese Patient (ISPCOP). In 2019, she was honored by D Magazine as one of Dallas' Best Doctors. She has also received the Distinguished Educator Award from the Society for Education in Anesthesia and the American Society of Anesthesiologists and was inducted into the prestigious Association of University Anesthesiologists (AUA). Dr. Moon is the principal investigator on multiple clinical research grants and has received numerous research awards. She has published more than two dozen original manuscripts, reviews, and book chapters and speaks internationally on topics related to her research. Dr. Moon resides in Dallas with her husband Daniel Moon, vice president and general counsel for jewelry and accessory brand Sam Moon. Together, they're parents to 6-year-old twin girls, Chloe and Madison, and Tiffany is stepmom to 16-year-old twins Nathan and Nicole. When she's not in front of the camera or saving lives, Dr. Moon also serves on the board of directors of The Family Place, an organization that empowers victims of family violence by providing safe housing, counseling, and skills that create independence while building community. To stay connected within the AHN community, please join our AHN directory: bit.ly/AHNDirectory --- Support this podcast: https://anchor.fm/asianhustlenetwork/support

Pregnancy can be a time of new physical challenges, and hypermobility may make the season even more complex. Hormones can change tissue elasticity and the body may struggle to adapt. Dr. Shanda Dorff began working with connective tissue disorders in 2008 and has helped countless women through pregnancies and beyond. She imparts her hard-learned wisdom to Bendy Bodies on this complicated subject. Dr. Dorff shares important considerations for someone with connective tissue disorders to consider in a pregnancy, and discusses higher-risk issues with various types of Ehlers-Danlos syndromes. She lists things to watch for during pregnancy, and gives advice on how to prepare for possible complications during a delivery. Dr. Dorff offers things to do - and avoid - during the post-partum weeks, as well as exercise considerations for hypermobile athletes during and after pregnancy. Finally, she reveals possible considerations for breastfeeding when hypermobile, and suggests ways to find specialists to help someone navigate a “bendy” pregnancy. For any bendy body considering pregnancy, as well as all healthcare providers, this episode shares decades of hard-won expertise with our listeners. Resources: https://hiddenstripes.com/ (Disjointed Book) https://www.complexcaresmn.com/ (Dr. Dorff's clinic) https://pubmed.ncbi.nlm.nih.gov/32148151/ (Drs. Dorff and Afrin article, Mast cell activation syndrome in pregnancy, delivery, postpartum and lactation: a narrative review) https://www.scirp.org/html/2-1920604_97524.htm#%23%23 (Drs. Chopra and Bluestein article Perioperative Care in Patients with Ehlers Danlos Syndromes) . . . . . #pregnancy #pregnant #podcast #EhlersDanlossyndromes #EhlersDanlos #BendyBodies #BendyBodiesPodcast #highriskpregnancy #zebrastrong #heds #hypermobile #connectivetissuedisorder #JenniferMilner #HypermobilityMD